FDA — authorised 18 January 1972
- Marketing authorisation holder: MEDA PHARMS
- Status: approved
🇺🇸 Anadrol-50 in United States
FDA authorised Anadrol-50 on 18 January 1972
Marketing authorisations
FDA — authorised 18 January 1972
- Application: NDA016848
- Marketing authorisation holder: PHARMOBEDIENT
- Local brand name: ANADROL-50
- Indication: TABLET — ORAL
- Status: approved
Anadrol-50 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Anadrol-50 approved in United States?
Yes. FDA authorised it on 18 January 1972; FDA authorised it on 18 January 1972.
Who is the marketing authorisation holder for Anadrol-50 in United States?
MEDA PHARMS holds the US marketing authorisation.